工程溶酶体崩用于癌症治疗:从机械学见解到纳米治疗创新
Weidong Fei1, Wenqiang Qian1, Yu Xin1
1Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
International journal of pharmaceutics
|February 7, 2026
概括
针对癌细胞中的关键器官 lysosomes,提供了一种新的抗癌策略. 纳米溶酶体的破坏可以诱导瘤细胞死亡,克服耐药性,减少转移,为新的癌症疗法铺平道路.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 细胞生物学 细胞生物学
背景情况:
- 瘤细胞中的溶酶体表现出改变的结构和功能,支持癌症的生存和抵抗力.
- 溶解体作为营养感知和应激适应的关键枢纽,在癌症治疗中呈现出脆弱性.
- 溶解体完整性是新兴抗癌干预措施的新目标.
研究的目的:
- 审查诱导溶酶体崩作为抗癌策略的治疗潜力.
- 专注于纳米治疗方法,以精确地破坏癌症治疗中的 lysosomal 功能.
主要方法:
- 目前关于瘤细胞中的 lysosomal 结构和功能的知识的系统总结.
- 对使用溶酶体失稳定治疗癌症的临床前研究的分析.
- 基于机制 (例如,气体生成,透性胀,氧化损伤) 的纳米治疗策略针对溶酶体的分类.
主要成果:
- 控制的溶酶体破坏有效诱导瘤细胞死亡并逆转耐药性.
- 纳米疗法可实现精确的溶酶体向,增强抗瘤疗效,降低毒性.
- 不同的 lysosome-targeting 策略显示出不同的优点和局限性,突出了合理纳米材料设计的需要.
结论:
- 溶解体是瘤生物学和潜在的治疗点的中央调节者.
- 色素向纳米疗法为克服癌症治疗障碍提供了一种多功能方法.
- 这一战略为精确,有效和机制驱动的抗癌干预提供了机会.
相关概念视频
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Lysosomes
26.3K
Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
26.3K
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Lysosomal Hydrolases
4.6K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.6K
What is Genetic Engineering?
80.3K
Overview
80.3K
Delivery Pathways to the Lysosome
9.8K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
9.8K


